Alamar Biosciences Inc.
ALMR | NASDAQ
$30.60
-$3.44 (-10.11%)
At close: Oct 30, 2026, 4:00 PM ET
$30.54
-$0.06 (-0.20%)
After-hours:
Oct 30, 2026, 7:30 PM ET
Company Profile
Alamar Biosciences operates as a commercial-stage proteomics firm, specializing in the highly sensitive, simultaneous identification of various proteins for both scientific research and prospective medical applications. Their integrated platform brings together proprietary instruments, specialized consumables, and unique software, forming a comprehensive, end-to-end solution. This system is designed for accurately quantifying multiple proteins, particularly those present in low concentrations, across a wide array of research and potential clinical uses.
Key Executives
| Name | Position |
|---|---|
| Yuling Luo | Co-Founder, Chairman & CEO |
| Justin J. McAnear | Chief Financial Officer |
| Xiao-Jun Ma | Chief Technology Officer |
| Alex Forrest-Hay | Senior Vice President of Sales |
| Anna Berdine | Senior Vice President of Marketing |
| Carrie Mendivil | Vice President of Investor Relations & Corporate Communications |
| Micah Litow | Senior VP of AI & Strategic Initiatives |
| Shiping Chen | Co-Founder, COO & Director |
| Stephen A. Williams | Chief Scientific Officer |
| Timothy O. White | President |
| Yiyuan Yin | Founder, VP of Technology & Acting Secretary |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Sep 16, 2026 | 4 | Filing |
| Sep 16, 2026 | 3 | Filing |
| Sep 03, 2026 | 4 | Filing |
| Sep 03, 2026 | 3 | Filing |
| Sep 01, 2026 | 8-K | Current Report |
| Aug 13, 2026 | SC 13G | Statement of acquisition of beneficial ownership b... |
| Aug 11, 2026 | SC 13G | Statement of acquisition of beneficial ownership b... |
| Aug 11, 2026 | 10-Q | Quarterly Report |
| Aug 10, 2026 | 8-K | Current Report |
| Jul 15, 2026 | 8-K | Current Report |
Alamar Biosciences Inc.
| Country | United States |
| IPO Date | Apr 17, 2026 |
| Industry | Biotechnology |
| Sector | Healthcare |
| Employees | 222 |
| CEO | Yuling Luo |
Contact Details
47071 Bayside Parkway Fremont,
California 94538 United States
Stock Details
| Ticker Symbol | ALMR |
| Exchange | NASDAQ |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| CIK Code | 0002104204 |
| CUSIP Number | 010911105 |
| ISIN Number | US0109111056 |
| SIC Code | 3826 |
Recent News
- 4 days ago / globenewswire.comEmory Researchers Identify Blood Protein Signature That Detects ALS With 98% Accuracy Using Alamar Technology
- 25 days ago / seekingalpha.comAlamar: The Consumables Flywheel Is Just Getting Started
- 1 month ago / globenewswire.comLancet Neurology Study Using Alamar Biosciences' Technology Reveals Divergent Biological Responses to Alzheimer's Treatment
- 3 months ago / seekingalpha.comAlamar Biosciences: The Content Flywheel Is More Valuable Than The Instrument
Add to Watchlist
Select watchlists to add or remove ALMR